Let's talk medical research

More than 80,000 people in the US will be diagnosed with bladder cancer this year. Treatment options have come a long way, and now include surgery, radiation, and chemotherapy — but many come with less than desirable side effects, and bladder cancer may recur. Research in this area is critical.

We recently announced a collaboration with Ben’s Friends, a network of online communities for people impacted by rare disease, and MyRareData, an organization that facilitates fundraising for advocacy groups through data, to bring information about clinical trials to the rare disease community.

With what we’re learning from the COVID-19 pandemic, can we create a permanent solution to keep the patient at the heart of clinical research? Last week a panel of experts, including our CEO, Laurent Schockmel, teamed up for an Ogilvy Consulting webinar, during which they discussed key industry considerations when it comes to putting patient centricity into action.

Biliary tract cancer (BTC) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile to the small intestine. There are three types of biliary tract cancer: Intrahepatic cholangiocarcinoma (ICC, or bile duct cancer), extrahepatic cholangiocarcinoma, and gallbladder cancer. While this form of cancer is particularly tough ...

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

In 2018, Antidote worked with SCORR Marketing and eight leading health organizations, including the Melanoma Research Alliance (MRA), to survey 4,000 patients about clinical research. About 10% of the total respondents self-identified as having melanoma.

For people living with inflammatory bowel disease (IBD), the symptoms – diarrhea, bleeding ulcers, stomach pain, cramping, and weight loss – can be emotionally, mentally, and physically difficult. Knowing the right things to say (or not say) and do can help you have more empathetic and thoughtful conversations with loved ones who have IBD. Below are 5 tips for supporting someone who lives with ...

A Q&A with Yvonne Taylor, Antidote’s senior clinical site operations manager Digital vendors work closely with clinical trial sites to ensure patient enrollment is going smoothly. We spoke with our very own Senior Clinical Site Operations Manager, Yvonne Taylor, about how clinical trial sites and vendors can best work together to provide a straightforward enrollment process for patients.

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that causes scarring of the lungs. Over time, the scarring worsens and it can become difficult to breathe. IPF has no cure and limited treatment options, making clinical research especially critical. In this case study, a pharma company approached Antidote to identify 600 IPF patients who would be eligible for their study in just six ...

In the midst of the COVID-19 pandemic, it seems like everything has gone digital, from scheduling video chat appointments with your doctor to Zoom conference calls, reading your newspapers online, and ordering groceries via an app. With the ability to reach more people online than ever before, clinical trial recruitment companies, too, have begun turning to digital channels even more to reach the ...